NuVasive
This article was originally published in The Gray Sheet
Executive Summary
Privately held maker of minimally invasive spinal surgery systems raises $29.3 mil. in an equity financing led by William Blair Capital Partners, firm reports May 21. Proceeds will be used to support the launch of the company's recently approved products, including the INS-1 intraoperative nerve surveillance system, which gained 510(k) clearance in November 2000 (1"The Gray Sheet" Dec. 11, 2000, p. 22). The San Diego company's other products include SpineArc surgical guide frame and the Vector cannulae for less traumatic access to the spine. Other investors included Sofinov and Kleiner Perkins Caulfield & Byers
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.